Global Eye Disorders Treatments Market Growth (Status and Outlook) 2025-2031

September 2025 | 90 pages | ID: G35857EC6AAEN
LP Information

Abstracts

According to this study, the global Eye Disorders Treatments market size will reach US$ million by 2031.

Most treatment of eye diseases is aimed at reducing inflammation, repairing traumatic injuries and improving or saving eyesight.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Eye Disorders Treatments Industry Forecast” looks at past sales and reviews total world Eye Disorders Treatments sales in 2024, providing a comprehensive analysis by region and market sector of projected Eye Disorders Treatments sales for 2025 through 2031. With Eye Disorders Treatments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eye Disorders Treatments industry.

This Insight Report provides a comprehensive analysis of the global Eye Disorders Treatments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Eye Disorders Treatments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eye Disorders Treatments market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eye Disorders Treatments and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eye Disorders Treatments.

This report presents a comprehensive overview, market shares, and growth opportunities of Eye Disorders Treatments market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cataract Surgery Devices
• Glaucoma Surgery Devices
• Vitreoretinal Surgery Devices
• Refractive Surgery Devices

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• Novartis
• Alimera Sciences
• Teva Pharmaceutical
• Eyetech Pharmaceuticals
• Refocus Group
• VisionCare Ophthalmic Technologies

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eye Disorders Treatments Market Size (2020-2031)
  2.1.2 Eye Disorders Treatments Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Eye Disorders Treatments by Country/Region (2020, 2024 & 2031)
2.2 Eye Disorders Treatments Segment by Type
  2.2.1 Cataract Surgery Devices
  2.2.2 Glaucoma Surgery Devices
  2.2.3 Vitreoretinal Surgery Devices
  2.2.4 Refractive Surgery Devices
2.3 Eye Disorders Treatments Market Size by Type
  2.3.1 Eye Disorders Treatments Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Eye Disorders Treatments Market Size Market Share by Type (2020-2025)
2.4 Eye Disorders Treatments Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Eye Disorders Treatments Market Size by Application
  2.5.1 Eye Disorders Treatments Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Eye Disorders Treatments Market Size Market Share by Application (2020-2025)

3 EYE DISORDERS TREATMENTS MARKET SIZE BY PLAYER

3.1 Eye Disorders Treatments Market Size Market Share by Player
  3.1.1 Global Eye Disorders Treatments Revenue by Player (2020-2025)
  3.1.2 Global Eye Disorders Treatments Revenue Market Share by Player (2020-2025)
3.2 Global Eye Disorders Treatments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EYE DISORDERS TREATMENTS BY REGION

4.1 Eye Disorders Treatments Market Size by Region (2020-2025)
4.2 Global Eye Disorders Treatments Annual Revenue by Country/Region (2020-2025)
4.3 Americas Eye Disorders Treatments Market Size Growth (2020-2025)
4.4 APAC Eye Disorders Treatments Market Size Growth (2020-2025)
4.5 Europe Eye Disorders Treatments Market Size Growth (2020-2025)
4.6 Middle East & Africa Eye Disorders Treatments Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Eye Disorders Treatments Market Size by Country (2020-2025)
5.2 Americas Eye Disorders Treatments Market Size by Type (2020-2025)
5.3 Americas Eye Disorders Treatments Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Eye Disorders Treatments Market Size by Region (2020-2025)
6.2 APAC Eye Disorders Treatments Market Size by Type (2020-2025)
6.3 APAC Eye Disorders Treatments Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Eye Disorders Treatments Market Size by Country (2020-2025)
7.2 Europe Eye Disorders Treatments Market Size by Type (2020-2025)
7.3 Europe Eye Disorders Treatments Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eye Disorders Treatments by Region (2020-2025)
8.2 Middle East & Africa Eye Disorders Treatments Market Size by Type (2020-2025)
8.3 Middle East & Africa Eye Disorders Treatments Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EYE DISORDERS TREATMENTS MARKET FORECAST

10.1 Global Eye Disorders Treatments Forecast by Region (2026-2031)
  10.1.1 Global Eye Disorders Treatments Forecast by Region (2026-2031)
  10.1.2 Americas Eye Disorders Treatments Forecast
  10.1.3 APAC Eye Disorders Treatments Forecast
  10.1.4 Europe Eye Disorders Treatments Forecast
  10.1.5 Middle East & Africa Eye Disorders Treatments Forecast
10.2 Americas Eye Disorders Treatments Forecast by Country (2026-2031)
  10.2.1 United States Market Eye Disorders Treatments Forecast
  10.2.2 Canada Market Eye Disorders Treatments Forecast
  10.2.3 Mexico Market Eye Disorders Treatments Forecast
  10.2.4 Brazil Market Eye Disorders Treatments Forecast
10.3 APAC Eye Disorders Treatments Forecast by Region (2026-2031)
  10.3.1 China Eye Disorders Treatments Market Forecast
  10.3.2 Japan Market Eye Disorders Treatments Forecast
  10.3.3 Korea Market Eye Disorders Treatments Forecast
  10.3.4 Southeast Asia Market Eye Disorders Treatments Forecast
  10.3.5 India Market Eye Disorders Treatments Forecast
  10.3.6 Australia Market Eye Disorders Treatments Forecast
10.4 Europe Eye Disorders Treatments Forecast by Country (2026-2031)
  10.4.1 Germany Market Eye Disorders Treatments Forecast
  10.4.2 France Market Eye Disorders Treatments Forecast
  10.4.3 UK Market Eye Disorders Treatments Forecast
  10.4.4 Italy Market Eye Disorders Treatments Forecast
  10.4.5 Russia Market Eye Disorders Treatments Forecast
10.5 Middle East & Africa Eye Disorders Treatments Forecast by Region (2026-2031)
  10.5.1 Egypt Market Eye Disorders Treatments Forecast
  10.5.2 South Africa Market Eye Disorders Treatments Forecast
  10.5.3 Israel Market Eye Disorders Treatments Forecast
  10.5.4 Turkey Market Eye Disorders Treatments Forecast
10.6 Global Eye Disorders Treatments Forecast by Type (2026-2031)
10.7 Global Eye Disorders Treatments Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Eye Disorders Treatments Forecast

11 KEY PLAYERS ANALYSIS

11.1 Johnson & Johnson
  11.1.1 Johnson & Johnson Company Information
  11.1.2 Johnson & Johnson Eye Disorders Treatments Product Offered
  11.1.3 Johnson & Johnson Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Johnson & Johnson Main Business Overview
  11.1.5 Johnson & Johnson Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Eye Disorders Treatments Product Offered
  11.2.3 Novartis Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Alimera Sciences
  11.3.1 Alimera Sciences Company Information
  11.3.2 Alimera Sciences Eye Disorders Treatments Product Offered
  11.3.3 Alimera Sciences Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Alimera Sciences Main Business Overview
  11.3.5 Alimera Sciences Latest Developments
11.4 Teva Pharmaceutical
  11.4.1 Teva Pharmaceutical Company Information
  11.4.2 Teva Pharmaceutical Eye Disorders Treatments Product Offered
  11.4.3 Teva Pharmaceutical Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Teva Pharmaceutical Main Business Overview
  11.4.5 Teva Pharmaceutical Latest Developments
11.5 Eyetech Pharmaceuticals
  11.5.1 Eyetech Pharmaceuticals Company Information
  11.5.2 Eyetech Pharmaceuticals Eye Disorders Treatments Product Offered
  11.5.3 Eyetech Pharmaceuticals Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eyetech Pharmaceuticals Main Business Overview
  11.5.5 Eyetech Pharmaceuticals Latest Developments
11.6 Refocus Group
  11.6.1 Refocus Group Company Information
  11.6.2 Refocus Group Eye Disorders Treatments Product Offered
  11.6.3 Refocus Group Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Refocus Group Main Business Overview
  11.6.5 Refocus Group Latest Developments
11.7 VisionCare Ophthalmic Technologies
  11.7.1 VisionCare Ophthalmic Technologies Company Information
  11.7.2 VisionCare Ophthalmic Technologies Eye Disorders Treatments Product Offered
  11.7.3 VisionCare Ophthalmic Technologies Eye Disorders Treatments Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 VisionCare Ophthalmic Technologies Main Business Overview
  11.7.5 VisionCare Ophthalmic Technologies Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Eye Disorders Treatments Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Eye Disorders Treatments Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cataract Surgery Devices
Table 4. Major Players of Glaucoma Surgery Devices
Table 5. Major Players of Vitreoretinal Surgery Devices
Table 6. Major Players of Refractive Surgery Devices
Table 7. Eye Disorders Treatments Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Eye Disorders Treatments Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Eye Disorders Treatments Market Size Market Share by Type (2020-2025)
Table 10. Eye Disorders Treatments Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Eye Disorders Treatments Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Eye Disorders Treatments Market Size Market Share by Application (2020-2025)
Table 13. Global Eye Disorders Treatments Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Eye Disorders Treatments Revenue Market Share by Player (2020-2025)
Table 15. Eye Disorders Treatments Key Players Head office and Products Offered
Table 16. Eye Disorders Treatments Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Eye Disorders Treatments Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Eye Disorders Treatments Market Size Market Share by Region (2020-2025)
Table 21. Global Eye Disorders Treatments Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Eye Disorders Treatments Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Eye Disorders Treatments Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Eye Disorders Treatments Market Size Market Share by Country (2020-2025)
Table 25. Americas Eye Disorders Treatments Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Eye Disorders Treatments Market Size Market Share by Type (2020-2025)
Table 27. Americas Eye Disorders Treatments Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Eye Disorders Treatments Market Size Market Share by Application (2020-2025)
Table 29. APAC Eye Disorders Treatments Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Eye Disorders Treatments Market Size Market Share by Region (2020-2025)
Table 31. APAC Eye Disorders Treatments Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Eye Disorders Treatments Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Eye Disorders Treatments Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Eye Disorders Treatments Market Size Market Share by Country (2020-2025)
Table 35. Europe Eye Disorders Treatments Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Eye Disorders Treatments Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Eye Disorders Treatments Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Eye Disorders Treatments Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Eye Disorders Treatments Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Eye Disorders Treatments
Table 41. Key Market Challenges & Risks of Eye Disorders Treatments
Table 42. Key Industry Trends of Eye Disorders Treatments
Table 43. Global Eye Disorders Treatments Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Eye Disorders Treatments Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Eye Disorders Treatments Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Eye Disorders Treatments Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Johnson & Johnson Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 48. Johnson & Johnson Eye Disorders Treatments Product Offered
Table 49. Johnson & Johnson Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Johnson & Johnson Main Business
Table 51. Johnson & Johnson Latest Developments
Table 52. Novartis Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 53. Novartis Eye Disorders Treatments Product Offered
Table 54. Novartis Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Alimera Sciences Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 58. Alimera Sciences Eye Disorders Treatments Product Offered
Table 59. Alimera Sciences Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Alimera Sciences Main Business
Table 61. Alimera Sciences Latest Developments
Table 62. Teva Pharmaceutical Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 63. Teva Pharmaceutical Eye Disorders Treatments Product Offered
Table 64. Teva Pharmaceutical Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Teva Pharmaceutical Main Business
Table 66. Teva Pharmaceutical Latest Developments
Table 67. Eyetech Pharmaceuticals Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 68. Eyetech Pharmaceuticals Eye Disorders Treatments Product Offered
Table 69. Eyetech Pharmaceuticals Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Eyetech Pharmaceuticals Main Business
Table 71. Eyetech Pharmaceuticals Latest Developments
Table 72. Refocus Group Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 73. Refocus Group Eye Disorders Treatments Product Offered
Table 74. Refocus Group Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Refocus Group Main Business
Table 76. Refocus Group Latest Developments
Table 77. VisionCare Ophthalmic Technologies Details, Company Type, Eye Disorders Treatments Area Served and Its Competitors
Table 78. VisionCare Ophthalmic Technologies Eye Disorders Treatments Product Offered
Table 79. VisionCare Ophthalmic Technologies Eye Disorders Treatments Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. VisionCare Ophthalmic Technologies Main Business
Table 81. VisionCare Ophthalmic Technologies Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Eye Disorders Treatments Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Eye Disorders Treatments Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Eye Disorders Treatments Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Eye Disorders Treatments Sales Market Share by Country/Region (2024)
Figure 8. Eye Disorders Treatments Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Eye Disorders Treatments Market Size Market Share by Type in 2024
Figure 10. Eye Disorders Treatments in Hospitals
Figure 11. Global Eye Disorders Treatments Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Eye Disorders Treatments in Clinics
Figure 13. Global Eye Disorders Treatments Market: Clinics (2020-2025) & ($ millions)
Figure 14. Eye Disorders Treatments in Others
Figure 15. Global Eye Disorders Treatments Market: Others (2020-2025) & ($ millions)
Figure 16. Global Eye Disorders Treatments Market Size Market Share by Application in 2024
Figure 17. Global Eye Disorders Treatments Revenue Market Share by Player in 2024
Figure 18. Global Eye Disorders Treatments Market Size Market Share by Region (2020-2025)
Figure 19. Americas Eye Disorders Treatments Market Size 2020-2025 ($ millions)
Figure 20. APAC Eye Disorders Treatments Market Size 2020-2025 ($ millions)
Figure 21. Europe Eye Disorders Treatments Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Eye Disorders Treatments Market Size 2020-2025 ($ millions)
Figure 23. Americas Eye Disorders Treatments Value Market Share by Country in 2024
Figure 24. United States Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Eye Disorders Treatments Market Size Market Share by Region in 2024
Figure 29. APAC Eye Disorders Treatments Market Size Market Share by Type (2020-2025)
Figure 30. APAC Eye Disorders Treatments Market Size Market Share by Application (2020-2025)
Figure 31. China Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 35. India Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Eye Disorders Treatments Market Size Market Share by Country in 2024
Figure 38. Europe Eye Disorders Treatments Market Size Market Share by Type (2020-2025)
Figure 39. Europe Eye Disorders Treatments Market Size Market Share by Application (2020-2025)
Figure 40. Germany Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 41. France Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Eye Disorders Treatments Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Eye Disorders Treatments Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Eye Disorders Treatments Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Eye Disorders Treatments Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 54. APAC Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 55. Europe Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 57. United States Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 58. Canada Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 59. Mexico Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 60. Brazil Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 61. China Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 62. Japan Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 63. Korea Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 65. India Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 66. Australia Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 67. Germany Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 68. France Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 69. UK Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 70. Italy Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 71. Russia Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 72. Egypt Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 73. South Africa Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 74. Israel Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 75. Turkey Eye Disorders Treatments Market Size 2026-2031 ($ millions)
Figure 76. Global Eye Disorders Treatments Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Eye Disorders Treatments Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Eye Disorders Treatments Market Size 2026-2031 ($ millions)